Beprogent

Beprogent

betamethasone + gentamicin

Manufacturer:

Hoe Pharma

Distributor:

Zuellig Pharma

Marketer:

Taisho Pharmaceutical
Concise Prescribing Info
Contents
Betamethasone dipropionate 0.064% w/w, gentamicin sulphate 0.17% w/w
Indications/Uses
Impetigo, erythema & other localised primary bacterial skin infection w/ a gm -ve component & also for secondary bacterial infections complicating other preexisting dermatoses.
Dosage/Direction for Use
Contraindications
Special Precautions
Discontinue use if irritation/sensitivity or overgrowth of non-susceptible organisms including fungi occurs. Prolonged treatment; treatment on extensive body areas; use w/ occlusive technique. Visual disturbance eg, blurred vision. Not suitable for ophth use. Pregnancy & lactation. Childn.
Adverse Reactions
Betamethasone: Burning sensation, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, skin maceration, secondary infection, skin atrophy, striae & miliaria. Gentamicin: Ototoxicity & nephrotoxicity.
MIMS Class
Topical Anti-Infectives with Corticosteroids
ATC Classification
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Beprogent topical cream
Packing/Price
15 g x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in